On Tuesday, Koninklijke Philips NV (PHIA:NA) (NYSE:AS:PHG) received an updated stock rating from Jefferies, moving from Underperform to Hold. The firm also increased its price target for the company's shares from EUR23.50 to EUR25.00. This adjustment comes in the wake of Philips' recent financial performance and market challenges.
The company has experienced negative order growth in the third quarter, with a surprising 2% drop in order intake. As a result, Philips has revised its sales guidance for the fiscal year 2024 downwards. The analyst from Jefferies noted that despite these setbacks, certain factors such as inconsistent royalties and strong profitability in the Diagnosis & Treatment (D&T) segment helped to mitigate weaker performance in other areas.
Philips has been grappling with several challenges, including a negative operational sales growth (OSG) in the third quarter, primarily due to difficult comparisons from previous periods and escalating headwinds in China. The company's performance in the Connected Care (CC) and Personal Health (PH) segments, as well as in Ultrasound and Imaging, was characterized as underwhelming, which impacted the margin trajectory for Connected Care.
The analyst's commentary highlighted the stock's recent plunge in value, suggesting that the current valuation now more accurately reflects the short-term obstacles Philips is facing. These include the impact of China's market conditions on the company's Personal Health and Ultrasound segments, the underperformance in Imaging, and the trajectory of margins in Connected Care.
Jefferies' upgrade indicates a shift in perspective on Philips' stock, recognizing that the current share price has factored in the immediate challenges the company is confronting. With the stock trading at a 20% discount compared to its peer Siemens Healthineers (SHL), the analyst believes that this new price target is a better representation of Philips' near-term prospects.
In other recent news, Philips has reported a stable performance in its Third Quarter 2024 Earnings Call, despite facing market challenges, particularly in China. The company has seen a slight decline in orders and flat sales but has managed to improve profitability. Philips has adjusted its full-year sales outlook to a modest growth range, with stronger prospects outside of China. The company's financial discipline is evident in an improved free cash flow and an adjusted EBITDA margin projected at 11.5%.
Philips anticipates growth in the Connected Care segment by 3%-5% and a slight decline in Personal Health. Despite challenges in China, particularly in the Personal Health segment, the company is seeing strong order growth in North America, specifically in the Diagnosis & Treatment segment. A restructuring charge of EUR 165 million is expected in the fourth quarter, including EUR 100 million related to Connected Care due to asset impairment.
Operational improvements and savings plans have contributed to the company's financial discipline, with over EUR 1.5 billion in savings achieved to date. The company remains committed to its three-year value creation plan, focusing on growth and margin expansion. These recent developments highlight Philips' resilience and commitment to navigate market challenges while maintaining a strong focus on profitability and efficiency.
InvestingPro Insights
Recent InvestingPro data and tips offer additional context to Philips' current market position and financial health, complementing Jefferies' updated rating. The company's market capitalization stands at $24.74 billion, reflecting its significant presence in the Healthcare Equipment & Supplies industry.
InvestingPro Tips highlight that Philips' net income is expected to grow this year, aligning with analysts' predictions that the company will return to profitability. This projection could provide some optimism amidst the challenges noted in the article. However, it's worth noting that Philips has not been profitable over the last twelve months, with a negative P/E ratio of -57.39.
The stock's recent performance has been volatile, with InvestingPro data showing a 17.05% decline in the past week and an 18.69% drop over the last month. This aligns with the article's mention of the stock's recent plunge. Despite these short-term setbacks, Philips has seen a 48.81% price return over the past year, suggesting longer-term resilience.
For investors seeking a more comprehensive analysis, InvestingPro offers 11 additional tips for Philips, providing a deeper understanding of the company's financial position and market trends.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.